These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21424908)

  • 21. Pathophysiology and Therapeutic Strategies for Symptomatic Uncomplicated Diverticular Disease of the Colon.
    Scaioli E; Colecchia A; Marasco G; Schiumerini R; Festi D
    Dig Dis Sci; 2016 Mar; 61(3):673-83. PubMed ID: 26458921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aminosalicylates.
    Gross V
    Dig Dis; 2012; 30(1):92-9. PubMed ID: 22572694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute diverticulitis of the colon--current medical therapeutic management.
    Tursi A
    Expert Opin Pharmacother; 2004 Jan; 5(1):55-9. PubMed ID: 14680435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging therapies for diverticular disease of the colon.
    Trivedi CD; Das KM;
    J Clin Gastroenterol; 2008; 42(10):1145-51. PubMed ID: 18936655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of complications and symptomatic recurrences in diverticular disease with mesalazine: a 12-month follow-up.
    Comparato G; Fanigliulo L; Cavallaro LG; Aragona G; Cavestro GM; Iori V; Maino M; Mazzocchi G; Muzzetto P; Colla G; Sianesi M; Franzé A; Mario FD
    Dig Dis Sci; 2007 Nov; 52(11):2934-41. PubMed ID: 17410435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucosal expression of basic fibroblastic growth factor, Syndecan 1 and tumor necrosis factor-alpha in diverticular disease of the colon: a case-control study.
    Tursi A; Elisei W; Brandimarte G; Giorgetti GM; Inchingolo CD; Nenna R; Picchio M; Giorgio F; Ierardi E
    Neurogastroenterol Motil; 2012 Sep; 24(9):836-e396. PubMed ID: 22680042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expanding applications: the potential usage of 5-aminosalicylic acid in diverticular disease.
    Tursi A; Joseph RE; Streck P
    Dig Dis Sci; 2011 Nov; 56(11):3112-21. PubMed ID: 21567193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of Diverticular Disease With Aminosalicylates: The Evidence.
    Barbara G; Cremon C; Barbaro MR; Bellacosa L; Stanghellini V
    J Clin Gastroenterol; 2016 Oct; 50 Suppl 1():S60-3. PubMed ID: 27622369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon.
    Tursi A; Brandimarte G; Daffinà R
    Dig Liver Dis; 2002 Jul; 34(7):510-5. PubMed ID: 12236485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diverticular disease: what is the best long-term treatment?
    Tursi A
    Nat Rev Gastroenterol Hepatol; 2010 Feb; 7(2):77-8. PubMed ID: 20134488
    [No Abstract]   [Full Text] [Related]  

  • 31. Review article: the pathophysiology and medical management of diverticulosis and diverticular disease of the colon.
    Tursi A; Papa A; Danese S
    Aliment Pharmacol Ther; 2015 Sep; 42(6):664-84. PubMed ID: 26202723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mesalazine and rifaximin in symptomatic uncomplicated diverticular disease.
    Festi D; Colecchia A
    Am J Gastroenterol; 2009 Feb; 104(2):532. PubMed ID: 19174809
    [No Abstract]   [Full Text] [Related]  

  • 33. Diverticular disease as a chronic illness: evolving epidemiologic and clinical insights.
    Strate LL; Modi R; Cohen E; Spiegel BM
    Am J Gastroenterol; 2012 Oct; 107(10):1486-93. PubMed ID: 22777341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New medical strategies for the management of acute diverticulitis.
    Tursi A
    Expert Rev Gastroenterol Hepatol; 2015; 9(10):1293-304. PubMed ID: 26289102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Modern therapy of diverticular disease].
    Leifeld L; Kruis W
    Internist (Berl); 2008 Dec; 49(12):1415-6, 1418-20. PubMed ID: 18946642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review article: the current and evolving treatment of colonic diverticular disease.
    Tursi A; Papagrigoriadis S
    Aliment Pharmacol Ther; 2009 Sep; 30(6):532-46. PubMed ID: 19549266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mesalazine for People with Diverticular Disease: A Systematic Review of Randomized Controlled Trials.
    Iannone A; Ruospo M; Wong G; Barone M; Principi M; Di Leo A; Strippoli GFM
    Can J Gastroenterol Hepatol; 2018; 2018():5437135. PubMed ID: 30320044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mesalamine in Recurrent Acute Colonic Diverticulitis.
    Dai C; Jiang M; Sun MJ
    Am J Gastroenterol; 2016 Nov; 111(11):1656-1657. PubMed ID: 27808151
    [No Abstract]   [Full Text] [Related]  

  • 39. Mesalamine (5-ASA) for the prevention of recurrent diverticulitis (Review).
    Carabotti M; Annibale B
    Tech Coloproctol; 2019 Jun; 23(6):597-599. PubMed ID: 31346815
    [No Abstract]   [Full Text] [Related]  

  • 40. Diverticular disease: evolving concepts in classification, presentation, and management.
    Mosadeghi S; Bhuket T; Stollman N
    Curr Opin Gastroenterol; 2015 Jan; 31(1):50-5. PubMed ID: 25426969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.